<DOC>
	<DOCNO>NCT00346463</DOCNO>
	<brief_summary>Growth retardation utero may cause uteroplacental vascular insufficiency . When Doppler ultrasound study umbilical artery abnormal pathological intrauterine growth restriction ( IUGR ) diagnose . IUGR fetuses high mortality morbidity , perinatally long term . This probably due chronic malnourishment hypoxia due placental insufficiency . This placental dysfunction cause generation harmful free oxygen radical fetus . The IUGR fetus diminish antioxidative capacity mean free radical buffer sufficiently . This lead fetal oxidative stress . Previous study show allopurinol inhibit cascade lead generation free radical . High dose allopurinol also scavenge radical bind free iron without adverse effect fetus mother . As IUGR associate placental insufficiency excessive production free radical hypothesize antenatal allopurinol administration could lead decrease oxidative stress mother fetus subsequent improvement maternal and/or neonatal outcome .</brief_summary>
	<brief_title>Antenatal Allopurinol Intrauterine Growth Restriction</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Mothers gestational age ( GA ) 30 36 week : Foetal growth retardation ( growth &lt; 10th percentile ) Abnormal Doppler flow umbilical cord ( umbilical artery pulsatility index ( PI ) &gt; 95th percentile ) Congenital , chromosomal syndromal abnormality Positive screen intrauterine viral infection Mothers gout high uric acid creatinine &gt; 100 umol/l ASAT &gt; 80 U/l , ALAT &gt; 80 U/l Uric acid &gt; 0,50 mmol/l</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Allopurinol</keyword>
	<keyword>Fetal Growth Retardation</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Placental Insufficiency</keyword>
</DOC>